0000899243-16-029944.txt : 20160923 0000899243-16-029944.hdr.sgml : 20160923 20160923183243 ACCESSION NUMBER: 0000899243-16-029944 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160922 FILED AS OF DATE: 20160923 DATE AS OF CHANGE: 20160923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ODONNELL FRANCIS E JR CENTRAL INDEX KEY: 0001066040 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 161900727 MAIL ADDRESS: STREET 1: BIODELIVERY SCIENCES INTERNATIONAL, INC STREET 2: 4131 PARKLAKE AVENUE, SUITE #225 CITY: RALEIGH STATE: NC ZIP: 27612 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-09-22 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001066040 ODONNELL FRANCIS E JR C/O BIODELIVERY SCIENCES INTL, INC., 4131 PARKLAKE AVENUE, SUITE 225 RALEIGH NC 27612 1 0 0 0 Common Stock 2016-09-22 4 S 0 50000 2.45 D 1335490 I By HCG II, LLC Common Stock 2016-09-23 4 S 0 50000 2.68 D 1285490 I By HCG II, LLC On September 22, 2016, Hopkins Capital Group II, LLC ("HCGII") sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $2.45 per share. The highest sale price for the Common Stock was $2.47 per share and the lowest sale price was $2.43 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents all of the shares of the Issuer held by HCGII. The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII. On September 23, 2016, HCGII sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $2.68 per share. The highest sale price for the Common Stock was $2.81 per share and the lowest sale price was $2.58 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Francis E. O'Donnell, Jr. 2016-09-23